Profile data is unavailable for this security.
About the company
Indaptus Therapeutics, Inc. is a clinical biotechnology company. The Company is focused on enhancing and expanding curative cancer immunotherapy for patients with unresectable or metastatic solid tumors and lymphomas. It designs its approach by targeting specific tumor or viral antigens. Its lead candidate, Decoy20, through pre-clinical development. Its platform is based on the hypothesis that require anti-tumor immunotherapy to activate both innate and adaptive cellular immunity in both tumors and immune organs. Its approach uses multi-targeted package of bacterial pathogen-associated molecular patterns (PAMPs), in the form of attenuated and killed, intact but non-pathogenic bacteria delivered intravenously. Its intravenous therapeutic candidates target the liver, spleen, and leaky vasculature of tumors, producing immune activation in an immune organ, as well as a common site for primary and metastatic cancer and hepatitis B virus (HBV) infection.
- Revenue in USD (TTM)0.00
- Net income in USD-15.42m
- Incorporated2021
- Employees7.00
- LocationIndaptus Therapeutics Inc3 Columbus Circle, 15Th FloorNEW YORK 10019United StatesUSA
- Phone+1 (646) 427-2727
- Websitehttps://indaptusrx.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calidi Biotherapeutics Inc | 0.00 | -28.74m | 20.17m | 38.00 | -- | -- | -- | -- | -0.6324 | -0.6324 | 0.00 | -0.0241 | 0.00 | -- | -- | 0.00 | -284.51 | -- | -- | -- | -- | -- | -- | -- | -- | -25.25 | 1.25 | -- | -89.98 | -- | -132.57 | -- | -- | -- |
Onconova Therapeutics Inc | 226.00k | -20.18m | 20.37m | 16.00 | -- | 1.40 | -- | 90.15 | -0.9628 | -0.9628 | 0.0108 | 0.6912 | 0.0064 | -- | 9.83 | 14,125.00 | -57.00 | -73.40 | -75.02 | -105.42 | -- | -- | -8,930.97 | -2,496.26 | -- | -- | 0.00 | -- | 0.00 | -22.08 | -17.33 | -- | -- | -- |
Pharmacyte Biotech Inc | 0.00 | -14.82m | 20.65m | 2.00 | -- | 0.6627 | -- | -- | -1.64 | -1.64 | 0.00 | 5.74 | 0.00 | -- | -- | 0.00 | -1.53 | -13.35 | -1.62 | -13.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1.81 | -- | -- | -- |
Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 20.73m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
Synlogic Inc | 3.37m | -57.28m | 20.73m | 6.00 | -- | 0.3833 | -- | 6.15 | -11.41 | -11.41 | 0.6581 | 4.64 | 0.0362 | -- | -- | 561,833.30 | -61.46 | -40.57 | -74.45 | -43.82 | -- | -- | -1,699.26 | -3,245.93 | -- | -- | 0.00009 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
Neurobo Pharmaceuticals Inc | 0.00 | -11.83m | 21.06m | 4.00 | -- | 0.9674 | -- | -- | -6.57 | -6.57 | 0.00 | 4.49 | 0.00 | -- | -- | 0.00 | -69.64 | -117.77 | -85.61 | -175.28 | -- | -- | -- | -- | -- | -6.13 | 0.00 | -- | -- | -- | 8.62 | -- | -- | -- |
KALA BIO Inc | 0.00 | -46.42m | 21.14m | 34.00 | -- | 1.88 | -- | -- | -22.73 | -22.73 | 0.00 | 4.17 | 0.00 | -- | -- | 0.00 | -63.23 | -54.04 | -96.42 | -63.22 | -- | -- | -- | -1,642.63 | -- | -11.62 | 0.7512 | -- | -65.37 | -- | 68.57 | -- | -8.20 | -- |
Galecto Inc | 0.00 | -38.35m | 21.15m | 13.00 | -- | 0.6541 | -- | -- | -1.45 | -1.45 | 0.00 | 1.19 | 0.00 | -- | -- | 0.00 | -68.84 | -48.46 | -81.18 | -52.36 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.77 | -- | -- | -- |
Indaptus Therapeutics Inc | 0.00 | -15.42m | 21.26m | 7.00 | -- | 1.73 | -- | -- | -1.84 | -1.84 | 0.00 | 1.44 | 0.00 | -- | -- | 0.00 | -71.76 | -66.55 | -83.87 | -81.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -7.68 | -- | -- | -- |
Iterum Therapeutics PLC | 0.00 | -31.10m | 21.36m | 14.00 | -- | 6.04 | -- | -- | -2.44 | -2.44 | 0.00 | 0.2632 | 0.00 | -- | -- | 0.00 | -55.89 | -120.83 | -71.18 | -190.99 | -- | -- | -- | -40,639.07 | -- | -- | 0.8509 | -- | -- | -- | 51.47 | -- | -40.22 | -- |
AIM ImmunoTech Inc | 193.00k | -20.78m | 21.64m | 22.00 | -- | 0.9866 | -- | 112.11 | -0.429 | -0.429 | 0.004 | 0.4632 | 0.0052 | -- | 8.04 | 8,772.73 | -56.04 | -39.18 | -62.45 | -41.49 | 84.46 | -262.90 | -10,764.25 | -7,630.97 | -- | -- | 0.00 | -- | 4.44 | -20.25 | -1.66 | -- | 31.47 | -- |
Zivo Bioscience Inc | 27.65k | -7.78m | 21.75m | 8.00 | -- | -- | -- | 786.58 | -4.62 | -4.62 | 0.0163 | -0.9259 | 0.0206 | -- | -- | 3,456.25 | -580.66 | -376.60 | -- | -- | 41.99 | -- | -28,127.23 | -96,315.32 | -- | -97.39 | -- | -- | -- | -- | 11.07 | -- | -- | -- |
Movano Inc | 0.00 | -31.25m | 21.79m | 34.00 | -- | 4.07 | -- | -- | -0.7704 | -0.7704 | 0.00 | 0.0973 | 0.00 | -- | -- | 0.00 | -208.03 | -- | -310.26 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -25.01 | -- | -- | -- |
Qilian International Holding Group Ltd | 46.47m | -7.78m | 21.81m | 298.00 | -- | 0.5097 | -- | 0.4693 | -0.2176 | -0.2176 | 1.30 | 1.20 | 0.8027 | 6.45 | 33.30 | 155,944.60 | -14.03 | 2.71 | -16.84 | 3.86 | 3.77 | 11.66 | -17.48 | 2.72 | 4.43 | -0.4812 | 0.0107 | 26.11 | -28.35 | -1.60 | -822.64 | -- | 12.86 | -- |
Earth Science Tech Inc | 5.98m | 330.94k | 22.04m | 8.00 | 72.92 | 10.21 | 41.64 | 3.68 | 0.001 | 0.001 | 0.0195 | 0.0069 | 3.16 | 11.41 | 106.07 | 747,970.00 | 17.50 | -224.84 | 42.70 | -- | 62.29 | 37.79 | 5.53 | -333.58 | 0.386 | -0.3899 | 0.1023 | -- | 243.77 | -36.31 | -111.95 | -- | -- | -- |
Context Therapeutics Inc | 0.00 | -23.96m | 22.07m | 5.00 | -- | 1.86 | -- | -- | -1.50 | -1.50 | 0.00 | 0.7435 | 0.00 | -- | -- | 0.00 | -88.71 | -- | -102.79 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -61.53 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
The Vanguard Group, Inc.as of 31 Dec 2023 | 256.27k | 3.05% |
The Investment House LLCas of 31 Dec 2023 | 102.44k | 1.22% |
Geode Capital Management LLCas of 31 Dec 2023 | 54.77k | 0.65% |
Strategy Asset Managers LLCas of 31 Dec 2023 | 45.34k | 0.54% |
Pine Valley Investments LLCas of 31 Dec 2023 | 44.24k | 0.53% |
Renaissance Technologies LLCas of 31 Dec 2023 | 29.40k | 0.35% |
Vivaldi Capital Management LPas of 31 Dec 2023 | 24.00k | 0.29% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 19.47k | 0.23% |
Citadel Securities LLCas of 31 Dec 2023 | 16.52k | 0.20% |
Tower Research Capital LLCas of 31 Dec 2023 | 4.70k | 0.06% |